Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds bacterium or component thereof or substance produced...
Patent
1993-10-20
1995-07-11
Wu, Sean M.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds bacterium or component thereof or substance produced...
560 9, 560 18, 534 14, A61K 5104, C07C32100, C07F 1300
Patent
active
054319005
ABSTRACT:
Radiopharmaceuticals consisting essentially of a lipophilic, charge neutral radionuclide complex of a diaminedithiol ligand having 1-4 ester groups of the formula --A--COOR where A is a straight or branched chain alkylene of 0-10 carbon atoms and R is an alkyl group of 1-10 carbon atoms are useful in radioimaging brain perfusion in primates. Ester-substituted diaminedithiols in sterile, pharmaceutically acceptable form, and kits of the diaminedithiols and sterile, non-pyrogenic reducing agents for reducing preselected radionuclides are also provided. Technetium-99m is a preferred radionuclide.
REFERENCES:
patent: 2810753 (1957-10-01), Bersworth
patent: 4284619 (1981-08-01), Lin
patent: 4434151 (1984-02-01), Byrne et al.
patent: 4444690 (1984-04-01), Fritzberg
patent: 4571430 (1986-02-01), Byrne et al.
patent: 4575556 (1986-03-01), Byrne et al.
patent: 4615876 (1986-10-01), Troutner et al.
patent: 4638051 (1987-01-01), Burns et al.
patent: 4673562 (1987-06-01), Davison et al.
patent: 4746505 (1988-05-01), Jones et al.
patent: 4897255 (1990-01-01), Fritzberg et al.
patent: 4963688 (1990-10-01), Bodor
patent: 5037631 (1991-08-01), Nosco
patent: 5175343 (1992-12-01), Fritzberg et al.
patent: 5279811 (1994-01-01), Bergstein et al.
European Search Report-EP 88102252.9.
J. Nucl. Med., 23 (9), 801-809 (1982).
J. Nucl. Med., 23 (7) 592-598 (1982).
J. Nucl. Med., 22 (3), 258-263 (1981).
J. Nucl. Med., 24 (4), 353-355 (1983).
Inorganic Chem., 20 (6), 1629-32 (1981).
Radiopharmaceutical Chem., Abstracts, 333 (Aug. 1982).
J. Nucl. Med., 23 (5), 17 (1982).
J. Nucl. Med., 22 (6), pp. 38, 51, 52 (1981).
J. Nucl. Med., 24 (5), 80 (1983).
J. Nucl. Med., 20 (6), 653 (1979).
J. Nucl. Med., 22 (6), 57-58, 641 (1979).
Can J. Chem., 45, 49 (1967).
J. Am. Chem. Soc., 108, 1351 (1986).
Fritzberg, A. R. "Advances in Tc-Labeling of Antibodies", Nucl. Med. 1987, 26. 7-12.
Bergstein Paul L.
Cheesman Edward H.
Watson Alan D.
Boudreaux Gerald J.
The Du Pont Merck Pharmaceutical Company
Wu Sean M.
LandOfFree
Ester-substituted diaminedithiols and radiolabeled complexes the does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ester-substituted diaminedithiols and radiolabeled complexes the, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ester-substituted diaminedithiols and radiolabeled complexes the will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-501752